Medication info
Glipham 2/500 mg Tablets

Glipham 2/500 mg Tablets

Prescription medicationTabletOral
Ingredient · strength
Glimepiride›2mg / 1 tabletMetformin Hydrochloride›500mg / 1 tablet
Manufacturer / importer
Donggu Bio Pharmaceutical Co., Ltd.
Appearance
White oblong film-coated tablets
Packaging
30 tablets/bottle, 100 tablets/bottle, 30 tablets/box [(10 tablets/PTP x 3)]
Approval status
Active

MFDS item code 201109280 · Approved 2011.10.31 · Insurance code 657305730

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who takes it
Adults
Adult dose
This medicine is administered 1 to 2 times daily immediately before or with meals. The dose may be adjusted considering each patient's current treatment regimen, efficacy, and tolerability; appropriate blood glucose monitoring should be performed for this purpose. Treatment is generally initiated at a low dose, which may be adjusted based on the patient's current medications and blood glucose levels. In clinical trials, the initial daily dose was glimepiride/metformin hydrochloride 2mg/500mg, and there is experience of gradually increasing the dose based on blood glucose monitoring results up to glimepiride/metformin hydrochloride 8mg/2000mg. For glimepiride monotherapy, there is generally little additional effect at doses above 4mg per day, although some patients showed better metabolic control when the dose was increased to 6mg (or 8mg). When used as an alternative to combination therapy, administer according to the dosage and administration of the glimepiride and metformin hydrochloride currently being taken in combination. Even if a previous dose is missed, do not take more than a single dose at the next scheduled administration.

Ingredients

Manufacturer
Donggu Bio Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

View approved original text

This medication is used to assist patients with type 2 diabetes in controlling blood sugar levels while practicing dietary and exercise therapies. Glimepiride and Metformin work together to effectively lower and manage blood sugar levels. Thus, taking this medication is expected to facilitate better blood sugar control, helping maintain a healthier lifestyle.

How to take

Adult dose

This medicine is administered 1 to 2 times daily immediately before or with meals. The dose may be adjusted considering each patient's current treatment regimen, efficacy, and tolerability; appropriate blood glucose monitoring should be performed for this purpose. Treatment is generally initiated at a low dose, which may be adjusted based on the patient's current medications and blood glucose levels. In clinical trials, the initial daily dose was glimepiride/metformin hydrochloride 2mg/500mg, and there is experience of gradually increasing the dose based on blood glucose monitoring results up to glimepiride/metformin hydrochloride 8mg/2000mg. For glimepiride monotherapy, there is generally little additional effect at doses above 4mg per day, although some patients showed better metabolic control when the dose was increased to 6mg (or 8mg). When used as an alternative to combination therapy, administer according to the dosage and administration of the glimepiride and metformin hydrochloride currently being taken in combination. Even if a previous dose is missed, do not take more than a single dose at the next scheduled administration.

Precautions

This medication may cause severe lactic acidosis or hypoglycemia, so administration should be discontinued if kidney function deteriorates rapidly. It is advisable to temporarily stop taking this medication and consult a doctor if symptoms such as dehydration, severe diarrhea, vomiting, or fever occur. Patients with poor kidney function or the elderly should use this medication with special caution and undergo regular kidney function tests. Patients with cardiovascular diseases or those who have experienced myocardial infarction in the past should be cautious when using this medication. This medication should not be administered to insulin-dependent diabetes patients, those with acute metabolic acidosis, severe liver dysfunction, pregnant or breastfeeding women. Patients at higher risk of hypoglycemia, those with poor nutritional status, and heavy alcohol consumers should be particularly cautious when using this medication. During the course of this medication, patients should be well-informed about symptoms of hypoglycemia and lactic acidosis, and should alert a doctor immediately if symptoms occur. Gastrointestinal side effects such as diarrhea, nausea, vomiting, and abdominal bloating may occur, although they are usually temporary. If skin rashes or allergic reactions occur, immediate medical attention should be sought. This medication has many drug interactions, so patients should inform their doctor or pharmacist of any other medications they are taking. Pregnant or breastfeeding women are advised not to use this medication and should switch to insulin therapy if necessary. Children and the elderly require special attention and regular testing when using this medication. In the case of overdose, severe hypoglycemia or lactic acidosis may occur, requiring immediate emergency treatment. This medication should be taken in conjunction with regular meals and exercise, and blood sugar and kidney function should be monitored regularly. Caution is needed when driving or operating machinery as symptoms of hypoglycemia or drowsiness may occur. Store this medication out of the reach of children, and do not transfer it to other containers.

Side effects

Lactic acidosis, hypoglycemia, diarrhea, nausea, vomiting, abdominal bloating, anorexia, indigestion, constipation, abdominal pain, discomfort, metallic taste, visual impairment, taste disorder, erythema, pruritus, urticaria, thrombocytopenia, leukopenia, hemolytic anemia, erythrocytopenia, granulocytopenia, agranulocytosis, pancytopenia, peripheral neuropathy, vitamin B12 deficiency, increase in hepatic enzymes, liver function impairment, bile secretion disorder, jaundice, hepatitis, allergic vasculitis, photosensitivity, decreased serum sodium concentration, decreased thyroid-stimulating hormone levels, magnesium deficiency, encephalopathy, hair loss, weight gain, headache due to hypoglycemia, severe hunger, fatigue, sleep disorders, instability, aggression, attention deficit, inability to focus, abnormal reaction, depression, confusion, speech disorder, aphasia, tremors, paralysis, sensory disturbance, dizziness, inability to self-regulate, delirium, cerebral convulsions, loss of consciousness, coma, weak respiration, slow pulse, sweating, clammy skin, anxiety, rapid pulse, hypertension, palpitations

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air from entering, and it is best kept at room temperature between 1 and 30 degrees Celsius. By storing it this way, the effectiveness of the medication can be maintained and used safely.

Appearance and packaging

Appearance

White oblong film-coated tablets

Package unit

30 tablets/bottle, 100 tablets/bottle, 30 tablets/box [(10 tablets/PTP x 3)]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.